Prof. Francesco Zaja is Director of the Department of Hematology at the University Hospital in Trieste, Italy. He received his MD from Bologna University in 1990, and obtained his postgraduate degree in Hematology from Udine University in 1995. He is a member of the directors of the Italian Society of Hematology and is the Chairman of the GIMEMA Thrombocytopenia and Anemia Working Group . An author or co-author of more than 260 publications with HI 66. Prof. Zaja's main research interests include immune thrombocytopenia and lymphomas. Principal oral presentations in international meeting: • ASH 2007: preliminary results of the phase III study dexamethasone vs dexamethasone and Rituximab in ITP • ASH 2008: final results of the phase III study dexamethasone vs dexamethasone and Rituximab in ITP (abst # 1 in plenary session) • ASCO 2009: the best of ASH • ASH 2010: final results of the phase II study lenalidomide plus dexamethasone salvage treatment in MCL • 13-International Conference on Malignant Lymphoma; Lugano 2015 • XXXVI World Congress of the International Society of Hematology: Glasgow 2016 Approach to refractory ITP